Literature DB >> 15117452

Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded.

William J Swiggard1, Una O'Doherty, David McGain, Deepa Jeyakumar, Michael H Malim.   

Abstract

We utilized quantitative methods to compare the efficiency of reverse transcription and stability of viral DNA within resting and activated T cells. Highly purified resting CD4(+) T cells and activated T cells from healthy donors were spinoculated with HIV-1(YU-2), then cultured in conditions that maintain both the viability and the quiescence of the resting cells. Spreading infection was suppressed, then kinetic PCR was used to relate the rates of synthesis of short (strong-stop, RU5) and long (gag or U3-gag second strand transfer) viral DNA to the mean number of virions initially bound to each type of cell. As shown previously, activated cells support an initial burst of high-level reverse transcription, which is then followed by a approximately 10-fold decay in cDNA levels over 4.5 days. In resting T cells, although the synthesis of late reverse transcripts was initially approximately 1000-fold less efficient than in activated T cells, the number of these cDNAs per bound input virion rose 10-fold as culture was extended to 4.5 days. The number of late reverse transcripts remained constant for 3 days after the addition of efavirinez, reflecting enhanced stability. In contrast, the short strong-step reverse transcripts were mostly degraded. Thus, late HIV-1 reverse transcripts can accumulate stably in resting T cells in the absence of detectable T cell activation. Defining the underlying basis for the stabilization of late reverse transcripts, and their associated nucleoprotein complexes, may be pertinent to the accumulation of reservoirs of latent HIV-1 in patients, and could provide a target for future therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117452     DOI: 10.1089/088922204322996527

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  35 in total

Review 1.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

Review 2.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Gregory Bristol; Thomas A Wilkinson; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.

Authors:  Luis M Agosto; Jianqing J Yu; Jihong Dai; Rachel Kaletsky; Daphne Monie; Una O'Doherty
Journal:  Virology       Date:  2007-07-13       Impact factor: 3.616

5.  HIV latency: present knowledge, future directions.

Authors:  Xavier Contreras; Tina Lenasi; B Matija Peterlin
Journal:  Future Virol       Date:  2006       Impact factor: 1.831

6.  High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections.

Authors:  Yoshiaki Nishimura; Reza Sadjadpour; Joseph J Mattapallil; Tatsuhiko Igarashi; Wendy Lee; Alicia Buckler-White; Mario Roederer; Tae-Wook Chun; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

7.  Differentially stimulated CD4+ T cells display altered human immunodeficiency virus infection kinetics: implications for the efficacy of antiviral agents.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Gregory Bristol; Jerome A Zack
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

8.  HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.

Authors:  John M Murray; John J Zaunders; Kristin L McBride; Yin Xu; Michelle Bailey; Kazuo Suzuki; David A Cooper; Sean Emery; Anthony D Kelleher; Kersten K Koelsch
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.

Authors:  William J Swiggard; Clifford Baytop; Jianqing J Yu; Jihong Dai; Chuanzhao Li; Richard Schretzenmair; Ted Theodosopoulos; Una O'Doherty
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

10.  Efficient delivery of lentiviral vectors into resting human CD4 T cells.

Authors:  X Geng; G Doitsh; Z Yang; N L K Galloway; W C Greene
Journal:  Gene Ther       Date:  2014-02-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.